MSR50 Comparing Survival Extrapolation Outcomes Using Different Network Meta-Analyses (NMA) Methods: An Application in Patients With Metastatic Renal Cell Carcinoma (MRCC) Treated With Immunotherapy (IO) Based Combinations

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1781
https://www.valueinhealthjournal.com/article/S1098-3015(22)03986-9/fulltext
Title : MSR50 Comparing Survival Extrapolation Outcomes Using Different Network Meta-Analyses (NMA) Methods: An Application in Patients With Metastatic Renal Cell Carcinoma (MRCC) Treated With Immunotherapy (IO) Based Combinations
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03986-9&doi=10.1016/j.jval.2022.09.1781
First page :
Section Title :
Open access? : No
Section Order : 11331
Categories :
Tags :
Regions :
ViH Article Tags :